Aytu Biopharma, Inc Income Statement

Income Statement Aug2009 Aug2010 Aug2011 Aug2012 Aug2013 Jun2014 Jun2015 Jun2016 Jun2017 Jun2018 Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Revenue & cost
Revenue 0.00M0.00M0.00M0.00M0.00M0.06M0.26M2.56M3.22M3.66M7.32M27.63M65.63M96.67M107.40M65.18M66.38M
Cost of Revenue 0.09M0.96M1.42M2.05M2.20M11.40M36.43M44.39M41.45M22.08M20.91M
Gross Profit 0.17M1.61M1.80M1.61M5.12M19.35M29.20M52.28M66.63M49.05M45.83M
Operating items
Amortization - Intangibles 0.09M0.66M1.71M1.55M2.14M4.49M6.01M5.84M4.79M3.68M3.68M
Research & Development 3.93M3.22M6.13M0.96M0.17M0.59M1.72M5.62M12.66M4.09M2.77M1.33M
Selling, General & Administrative 0.08M0.03M0.03M2.35M3.98M8.52M17.44M17.73M18.89M19.66M25.50M31.17M28.63M19.95M17.38M
Restructuring Costs 2.35M4.89M2.16M2.10M
Other Operating Expenses 0.05M0.02M0.02M0.69M9.62M4.94M5.46M-37.94M-35.32M-74.71M-110.17M50.97M25.77M32.85M
Operating Expenses 0.13M0.06M0.05M6.28M7.89M24.27M23.35M23.36M24.17M40.48M88.07M162.19M83.70M50.65M53.66M
Operating Income -0.13M-0.06M-0.05M-6.35M-7.63M-21.70M-20.13M-19.70M-16.85M-21.13M-58.87M-109.91M-17.07M-2.18M-7.83M
EBIT -0.13M-0.06M-0.05M-6.35M-7.63M-21.70M-20.13M-19.70M-16.85M-21.13M-58.87M-109.91M-17.07M-2.18M-7.83M
Non-operating items
Non Operating Investment Income -0.97M-0.06M
Interest & Investment Income -6.48M-2.38M
Other Non Operating Income 274.00274.00-0.01M0.21M6.28M0.08M-2.61M-2.05M1.60M4.79M-4.00M-1.70M
Non Operating Income -0.00M-0.00M-0.00M-0.11M-6.48M-2.38M9.51M-10.29M7.51M-2.05M1.02M0.18M0.87M-0.51M
Net income details
EBT -0.14M-0.06M-0.06M-6.39M-7.75M-28.18M-25.04M-20.45M-17.38M-13.62M-58.03M-108.89M-17.05M-10.38M-13.74M
Tax Provisions -0.81M-0.02M0.21M0.26M-0.11M0.13M2.14M0.65M
Profit After Tax 0.06M0.06M-0.14M-0.06M-0.06M-5.58M-7.72M-28.18M-22.51M-10.19M-27.13M-13.62M-58.30M-108.80M-17.05M-15.84M-14.18M
Other Income -0.43M
Income from Continuing Operations -0.14M-0.06M-0.06M-5.58M-7.72M-28.18M-25.26M-20.45M-17.38M-13.62M-58.29M-108.78M-17.18M-12.52M-14.40M
Consolidated Net Income -0.14M-0.06M-0.06M-5.58M-7.72M-28.18M-25.26M-20.45M-17.38M-13.62M-58.29M-108.78M-17.18M-3.32M0.62M
Income towards Parent Company -0.14M-0.06M-0.06M-5.58M-7.72M-28.18M-25.26M-20.45M-17.38M-13.62M-58.29M-108.78M-17.18M-3.32M0.62M
Net Income towards Common Stockholders -0.14M-0.06M-0.06M-5.58M-7.72M-28.18M-25.26M-20.45M-17.38M-13.62M-58.29M-108.78M-17.18M-3.32M0.62M
Additional items
EPS (Basic) -0.03-0.01-0.01-0.80-10.07-323.70-48.30-15.31-3.48-3.01-3.48-74.01-5.11-2.86-2.26
EPS (Weighted Average and Diluted) -3.48-74.01-5.11
Shares Outstanding (Weighted Average) 15.0047.00173.000.01M0.08M0.60M1.26M1.93M3.78M5.57M6.17M
Shares Outstanding (Diluted Average) 16.75M1.47M3.34M
EBITDA 0.06M0.06M0.45M-0.06M-0.05M-6.35M-7.63M-21.70M-20.13M-19.70M-16.85M-21.13M-58.87M-109.91M-17.07M-2.18M-7.83M
Interest Expenses 0.00M0.00M0.00M0.11M5.49M2.53M0.75M0.54M2.61M4.96M5.06M3.70M
Tax Rate 12.73%0.31%0.10%